17 December 2024 -- Paris, France -- Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare in the UK.

12 December 2024 -- Cambridge, UK -- electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7–10 Jan in Las Vegas, USA.

11 December 2024 -- Tramore, Republic of Ireland -- Astoriom, a global leader in the life sciences R&D sample stability and biorepository storage industry, has developed a new state-of-the-art cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland.

11 December 2024 -- Liege, Belgium -- Allegro NV, a biomedical company developing transformative nanotechnology-based devices for degenerative joint disease, today announced that its injectable microparticle gel, hydrocelin, has demonstrated favorable safety in two preclinical studies.

10 December 2024 -- Maryland, US -- Sapio Sciences, the science-aware lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025.

10 December 2024 -- London, UK -- The Pistoia Alliance has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center) on the impact of AI and copyright legislation on pharma R&D. While 83% of life science professionals are now using generative AI in their research, there is still widespread concern about the impact of differing AI regulations on cross-border research collaboration (85%).

5 December 2024 -- Hamburg, Germany -- Bio-aerosols aren’t welcome in any laboratory. They can consist of bacteria, cell fragments, fungal spores or viruses, as well as byproducts of microbial metabolism. Aerosols are easily generated in various concentrations during simple routine tasks in the laboratory, such as centrifugation, pipetting or shaking.

5 December 2024 -- Georgia, US -- Exotec, a global provider of warehouse automation and robotics solutions, has announced partnerships with two new organisations in the pharmaceutical sector: Hygie31 and Hartmann Group. Both companies will adopt Exotec’s Skypod robotic system to automate warehouse processes and increase efficiency.

4 December 2024 -- London, UK -- N4 Pharma Plc, the specialist preclinical stage biotech company announces a new lead programme, N4 101. This orally-delivered inflammation inhibitor for Irritable Bowel Disease (IBD) uses Nuvec®, the company’s novel silica non-viral, non-lipid nanoparticle delivery system, to overcome the challenges with current IBD treatments.

4 December 2024 -- Cambridge, UK -- Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.

3 December 2024 -- Karlsruhe, Germany -- Romaco Holding GmbH has just appointed Ann-Xiaoyan Li as new Group CFO and Managing Director of the Romaco Group. She succeeds Markus Kimpel, who has stepped out of the company at his own request. Romaco is an international manufacturer of processing and packaging technologies for the pharmaceutical, food and chemical industries.

3 December 2024 -- London, UK -- Duke Street Bio Ltd, a precision medicine biotech developing next-generation small molecule cancer therapies, is pleased to announce that the first patient has been dosed in a Phase I trial evaluating the highly selective PARP1 inhibitor, DSB2455, in patients with solid tumours. DSB2455 is a potentially best-in-class, potent CNS penetrant PARP1 inhibitor with profound selectivity over the closely related enzyme PARP2.